Geoffrey B. Pardo, Director at SpyGlass Pharma, Inc. (SGP), bought 2,187,513 shares at $16.00 ($5.0M) on 2026-02-09, disclosed to the SEC on 2026-02-11.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,875,013 | $0 | 0.0% |
| 2 | $16.00 | 312,500 | $5.0M | 100.0% |
| Total | $2.29 avg | 2,187,513 | $5.0M | 100% |
| Filing → |